Thrombotic thrombocytopenic purpura-haemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon beta

Mult Scler. 2014 Nov;20(13):1788-9. doi: 10.1177/1352458514529614. Epub 2014 Apr 2.

Author

Georgina Arrambide¹

Affiliation

¹ Servei de Neurologia-Neuroimmunologia. Centre d'Esclerosi Múltiple de Catalunya, (Cemcat). Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain garrambide@cem-cat.org.

PMID: 24696053
DOI: 10.1177/1352458514529614

No abstract available

Publication types

Comment

MeSH terms

Adjuvants, Immunologic / adverse effects*
Female
Hemolytic-Uremic Syndrome / chemically induced*
Humans
Interferon-beta / adverse effects*
Multiple Sclerosis, Relapsing-Remitting / drug therapy*
Purpura, Thrombotic Thrombocytopenic / chemically induced*

Substances

Adjuvants, Immunologic
Interferon-beta